Literature DB >> 30405820

Overexpression of sigma-1 receptor in MCF-7 cells enhances proliferation via the classic protein kinase C subtype signaling pathway.

Yuqi Wu1, Xueyan Bai1, Xiaoyang Li1, Chang Zhu1, Zachary P Wu1.   

Abstract

Sigma-1 receptor (sigma-1R), a 25-kDa integral membrane protein, is expressed at a high density in various tumor cell lines and its ligands mediate tumor cell proliferation. However, the effect of this receptor on proliferation and the associated intracellular molecules in tumors remains unclear. The present study aimed to investigate the effect of sigma-1R overexpression on MCF-7 cell proliferation and the associated intracellular molecules that serve a key role in this process. The sigma-1R proliferative function was examined by comparing the proliferation rates of a sigma-1R-overexpressing line, MCF-41 with a sigma-1R-defective line, MCF-7, in culture media with various serum concentrations. The results demonstrated that MCF-41 cells grew significantly faster compared with MCF-7 cells, indicating a proliferation-enhancing receptor function. This proliferation-enhancing effect was completely eliminated by adding a PKC inhibitor to the culture media for MCF-41 cells. To identify which PKC subtype affects the proliferative function of sigma-1R, five inhibitors of PKC subtypes or enzymes involved in the PKC signaling cascade were introduced to MCF-7 and MCF-41 cell culture media and their effects on cell proliferation were compared. It was revealed that only the classic PKC subtype inhibitor, GF109203×, significantly inhibited MCF-41 cell proliferation compared with the MCF-7 line. In conclusion, among PKC iso-enzymes only classic PKC subtype enzymes serve an important role in sigma-1R overexpression enhancing MCF-7 cell proliferation.

Entities:  

Keywords:  MCF-7; overexpression; proliferation; protein kinase C; sigma-1 receptor

Year:  2018        PMID: 30405820      PMCID: PMC6202530          DOI: 10.3892/ol.2018.9448

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  37 in total

Review 1.  Cell signaling by receptor tyrosine kinases.

Authors:  J Schlessinger
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 2.  PKC isozymes and diacylglycerol-regulated proteins as effectors of growth factor receptors.

Authors:  José Luis Oliva; Erin M Griner; Marcelo G Kazanietz
Journal:  Growth Factors       Date:  2005-12       Impact factor: 2.511

Review 3.  The molecular heterogeneity of protein kinase C and its implications for cellular regulation.

Authors:  Y Nishizuka
Journal:  Nature       Date:  1988-08-25       Impact factor: 49.962

4.  Elevated levels of ERK2 in human breast carcinoma MCF-7 cells transfected with protein kinase C alpha.

Authors:  A K Gupta; S S Galoforo; C M Berns; A A Martinez; P M Corry; K L Guan; Y J Lee
Journal:  Cell Prolif       Date:  1996-12       Impact factor: 6.831

Review 5.  Cell signaling by receptor tyrosine kinases.

Authors:  Mark A Lemmon; Joseph Schlessinger
Journal:  Cell       Date:  2010-06-25       Impact factor: 41.582

Review 6.  The pharmacology of sigma-1 receptors.

Authors:  Tangui Maurice; Tsung-Ping Su
Journal:  Pharmacol Ther       Date:  2009-07-18       Impact factor: 12.310

Review 7.  Potential applications for sigma receptor ligands in cancer diagnosis and therapy.

Authors:  Aren van Waarde; Anna A Rybczynska; Nisha K Ramakrishnan; Kiichi Ishiwata; Philip H Elsinga; Rudi A J O Dierckx
Journal:  Biochim Biophys Acta       Date:  2014-08-27

8.  Role of sigma-1 receptor C-terminal segment in inositol 1,4,5-trisphosphate receptor activation: constitutive enhancement of calcium signaling in MCF-7 tumor cells.

Authors:  Zhiping Wu; Wayne D Bowen
Journal:  J Biol Chem       Date:  2008-06-06       Impact factor: 5.157

9.  Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.

Authors:  B J Vilner; C S John; W D Bowen
Journal:  Cancer Res       Date:  1995-01-15       Impact factor: 12.701

10.  Kaposi's sarcoma-associated herpesvirus induces the phosphatidylinositol 3-kinase-PKC-zeta-MEK-ERK signaling pathway in target cells early during infection: implications for infectivity.

Authors:  Pramod P Naranatt; Shaw M Akula; Christopher A Zien; Harinivas H Krishnan; Bala Chandran
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

View more
  3 in total

Review 1.  Emerging Benefits: Pathophysiological Functions and Target Drugs of the Sigma-1 Receptor in Neurodegenerative Diseases.

Authors:  Ning-Hua Wu; Yu Ye; Bin-Bin Wan; Yuan-Dong Yu; Chao Liu; Qing-Jie Chen
Journal:  Mol Neurobiol       Date:  2021-08-12       Impact factor: 5.590

Review 2.  Revisiting the sigma-1 receptor as a biological target to treat affective and cognitive disorders.

Authors:  Kinga Sałaciak; Karolina Pytka
Journal:  Neurosci Biobehav Rev       Date:  2021-11-01       Impact factor: 8.989

3.  NO1, a New Sigma 2 Receptor/TMEM97 Fluorescent Ligand, Downregulates SOCE and Promotes Apoptosis in the Triple Negative Breast Cancer Cell Lines.

Authors:  Carlos Cantonero; Pedro Javier Camello; Carmen Abate; Francesco Berardi; Gines Maria Salido; Juan Antonio Rosado; Pedro C Redondo
Journal:  Cancers (Basel)       Date:  2020-01-21       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.